Unicycive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 02/14/2025 | 10.98 M | $8.72 M | 28.29% | 12.35% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 10.39 M | $8.25 M | 268.46% | 11.68% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 10.00 M | $7.94 M | 16.84% | 11.24% |
| VIVO CAPITAL, LLC | 02/13/2025 | 9.97 M | $7.92 M | 123.04% | 11.21% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 5.08 M | $4.03 M | 0.00% | 5.71% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 5.00 M | $3.97 M | 0.00% | 5.62% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.49 M | $1.97 M | -37.83% | 2.80% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 2.30 M | $1.83 M | 16.36% | 2.59% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 1.75 M | $1.39 M | -22.22% | 1.97% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 1.47 M | $1.17 M | 0.00% | 1.66% |
| VANGUARD GROUP INC | 02/11/2025 | 1.14 M | $903,747 | 0.00% | 1.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 524,487 | $416,547 | 30.34% | 0.59% |
| XTX TOPCO LTD | 02/13/2025 | 171,463 | $136,176 | 142.23% | 0.19% |
| STATE STREET CORP | 02/14/2025 | 125,236 | $99,462 | 185.04% | 0.14% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 73,608 | $58,459 | -21.21% | 0.08% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 72,272 | $57,398 | 0.63% | 0.08% |
| CREATIVE PLANNING | 02/14/2025 | 22,674 | $18,008 | 121.62% | 0.03% |
| HRT FINANCIAL LP | 02/14/2025 | 22,131 | $17,000 | 100.00% | 0.02% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 01/27/2025 | 15,500 | $12,310 | 0.00% | 0.02% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 01/23/2025 | 15,000 | $12,000 | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 10,888 | $8,645 | -52.21% | 0.01% |
| SOA WEALTH ADVISORS, LLC. | 02/06/2025 | 1,000 | $794 | 100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 587 | $466 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 199 | $158 | -3.86% | 0.00% |
| BOGART WEALTH, LLC | 01/30/2025 | 60 | $48 | 100.00% | 0.00% |
| 02/06/2025 | 49 | $39 | 100.00% | 0.00% | |
| UBS GROUP AG | 02/14/2025 | 1 | $1 | 100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLEAKLEY FINANCIAL GROUP, LLC | 01/27/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Unicycive Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:
GREAT POINT PARTNERS LLC: 10.98 M
Nantahala Capital Management, LLC: 10.39 M
Octagon Capital Advisors LP: 10 M
Vivo Capital, LLC: 9.97 M
Logos Global Management LP: 5.08 M
Walleye Capital LLC: 5 M
69.36% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.72 M shares in the last 24 months. This purchase volume represents approximately $46.91 M in transactions.